Population pharmacokinetic-pharmacodynamic modelling in oncology: a tool for predicting clinical response.

"Competing Interests All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare no support from any organization for the submitted work, no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years and no other relationships or activities that could appear to have influenced the submitted work."

"This work was funded by the Swedish Cancer Society and DDMoRe which is an Innovative Medicines Initiative Joint Undertaking under grant agreement n°115156, resources of which are composed of financial contributions from the European Union's Seventh Framework Programme (FP7/2007–2013) and EFPIA companies in kind contribution. The DDMoRe project is also supported by a financial contribution from Academic and SME partners. This work does not necessarily represent the view of all DDMoRe partners. Brendan Bender was funded by Genentech, Inc. Competing Interests: All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare no support from any organization for the submitted work, no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years and no other relationships or activities that could appear to have influenced the submitted work."